Know Cancer

or
forgot password

Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients


Phase 0
18 Years
N/A
Not Enrolling
Both
Patient Harboring Glioblastoma That Will Undergo Surgery

Thank you

Trial Information

Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients


Inclusion Criteria:



- Patients harboring Glioblastoma

- Patient will undergo surgery

Exclusion Criteria:

- BMI > 30

- Liver and Kidney Function so compromised that medication is prescribed

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Concentration of Curcumin in Glioblastoma

Outcome Description:

At the time of surgery

Outcome Time Frame:

At Tumor resection

Safety Issue:

No

Principal Investigator

Stephan Duetzmann

Investigator Role:

Principal Investigator

Investigator Affiliation:

Goethe University

Authority:

Regierungspräsidium Darmstadt: Germany

Study ID:

JohannWGUH_Curcumin-01

NCT ID:

NCT01712542

Start Date:

October 2012

Completion Date:

May 2013

Related Keywords:

  • Patient Harboring Glioblastoma That Will Undergo Surgery
  • Glioblastoma

Name

Location